Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 175 record(s)

Req # A-2021-000537

Adverse Drug Reaction (ADR) for ALIROCUMAB. Report number: E2B_03502076.

Organization: Health Canada

38 page(s)
March 2022

Req # A-2021-000664

Adverse Drug Reaction (ADR) for INSULIN ASPART. Report number: E2B_03454918.

Organization: Health Canada

53 page(s)
March 2022

Req # A-2021-001616

Adverse Drug Reaction (ADR) for VANDETANIB. Report Number: E2B_04386015.

Organization: Health Canada

22 page(s)
March 2022

Req # A-2021-001639

Adverse Drug Reaction (ADR) for LEVOMEPROMAZINE MALEATE. Report number: E2B_04128374.

Organization: Health Canada

39 page(s)
March 2022

Req # A-2021-001647

Adverse Drug Reaction (ADR) for DESOXIMETASONE. Report Number: E2B_03766482.

Organization: Health Canada

52 page(s)
March 2022

Req # A-2021-001656

Adverse Drug Reaction (ADRs) for RANITIDINE HYDROCHLORIDE. Report Numbers: E2B_04589242, E2B_01758072.

Organization: Health Canada

137 page(s)
March 2022

Req # A-2021-001668

Adverse Drug Reaction (ADR) for IPRATROPIUM BROMIDE. Report Number: E2B_04602334.

Organization: Health Canada

20 page(s)
March 2022

Req # A-2021-001670

Adverse Drug Reaction (ADR) for ZOPICLONE. Report Number: 960750.

Organization: Health Canada

10 page(s)
March 2022

Req # A-2021-001677

Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report Number: 000959916.

Organization: Health Canada

50 page(s)
March 2022

Req # A-2021-001678

Adverse Drug Reaction (ADRs) for GLYCERYL TRINITRATE. Report Number: 000960606.

Organization: Health Canada

107 page(s)
March 2022
Date modified: